Regulation
FDA doubles down on patient engagement to support rare disease research
For Rare Disease Day, several panels organised by the FDA discussed the importance overcoming accessibility barriers during drug development.
For Rare Disease Day, several panels organised by the FDA discussed the importance overcoming accessibility barriers during drug development.